IMVT
Immunovant Inc.
$17.28
+$0.25(+1.47%)
56
Overall
55
Value
83
Tech
31
Quality
Market Cap
$2.81B
Volume
626.45K
52W Range
$12.72 - $32.10
Target Price
$40.07
EPS Estimates Overview
| Current Quarter | $-0.73 | Next Quarter | $-0.72 |
| Current Year | $-2.89 | Next Year | $-2.95 |
| QoQ Growth | +1.4% | YoY Growth | -2.1% |
| 3Y EPS CAGR | N/A | Target Price | $40.07 |
| Consensus | Buy | Upside | +131.9% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMVT | $17.28 | +1.5% | 626.45K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |